0,996  0,001  Hedgehog signaling inhibitor
0,980  0,001  Embryotoxic
0,979  0,001  Teratogen
0,896  0,003  Radioprotector
0,816  0,015  Apoptosis agonist
0,756  0,003  Antineoplastic (bone cancer)
0,735  0,007  Antineoplastic (ovarian cancer)
0,723  0,003  Smo receptor antagonist
0,718  0,007  Antineoplastic (solid tumors)
0,720  0,016  CYP3A4 substrate
0,685  0,006  NOS3 expression inhibitor
0,608  0,005  Antineoplastic (sarcoma)
0,607  0,006  UGT1A4 substrate
0,603  0,010  Antineoplastic (pancreatic cancer)
0,633  0,045  Antiinflammatory
0,588  0,019  Respiratory analeptic
0,591  0,031  Antineoplastic (lung cancer)
0,537  0,005  Prostatic (benign) hyperplasia treatment
0,556  0,037  Transcription factor NF kappa B inhibitor
0,517  0,006  Antineoplastic (squamous cell carcinoma)
0,516  0,008  Antineoplastic (carcinoma)
0,537  0,030  Antiobesity
0,498  0,005  Contraceptive
0,492  0,005  Antineoplastic (gastric cancer)
0,513  0,029  Immunosuppressant
0,487  0,005  UGT2B7 substrate
0,481  0,006  Prostate disorders treatment
0,476  0,007  Abortion inducer
0,471  0,012  Interleukin 2 agonist
0,493  0,037  Antineoplastic (colorectal cancer)
0,488  0,035  Antineoplastic (colon cancer)
0,472  0,032  Bone diseases treatment
0,461  0,022  Antineoplastic (non-small cell lung cancer)
0,467  0,029  Cytotoxic
0,441  0,004  Androgen antagonist
0,440  0,006  Lipocortins synthesis antagonist
0,460  0,032  Antihypercholesterolemic
0,451  0,027  Antiosteoporotic
0,441  0,022  UGT2B4 substrate
0,446  0,029  Analeptic
0,434  0,017  UDP-glucuronosyltransferase substrate
0,449  0,041  Prostate cancer treatment
0,427  0,022  Nitric oxide antagonist
0,431  0,032  AR expression inhibitor
0,457  0,064  Antineoplastic (breast cancer)
0,450  0,067  Antidiabetic
0,450  0,067  Cyclophilin D inhibitor
0,395  0,018  Sodium/bile acid cotransporter inhibitor
0,412  0,047  Cholesterol antagonist
0,393  0,029  Chemopreventive
0,372  0,009  Antiviral (Influenza A)
0,362  0,015  Antiacne
0,359  0,017  Antiviral (Influenza)
0,383  0,040  CTGF expression inhibitor
0,386  0,046  ICAM1 expression inhibitor
0,349  0,014  Hair growth stimulant
0,337  0,008  Protein-tyrosine phosphatase 1B inhibitor
0,366  0,039  Cytostatic
0,333  0,016  Interferon gamma antagonist
0,321  0,008  UGT2B9 substrate
0,349  0,039  Proliferative diseases treatment
0,311  0,009  Endometrios treatment
0,354  0,058  Hepatic disorders treatment
0,295  0,002  Glycine receptor agonist
0,308  0,018  Protein-tyrosine phosphatase inhibitor
0,343  0,055  CYP3A4 inhibitor
0,295  0,007  Contraceptive male
0,345  0,058  Apoptosis antagonist
0,307  0,030  UGT1A1 substrate
0,332  0,059  Antineoplastic (brain cancer)
0,285  0,013  Cholesterol synthesis inhibitor
0,351  0,090  Antipruritic, allergic
0,308  0,048  Antineoplastic (liver cancer)
0,255  0,005  Postmenopausal disorders treatment
0,261  0,015  Psychosexual dysfunction treatment
0,247  0,004  Androgen agonist
0,296  0,057  Sensitization
0,239  0,003  Glycine receptor antagonist
0,271  0,038  Hepatoprotectant
0,270  0,042  Anesthetic general
0,237  0,009  Contraceptive female
0,294  0,072  Antineoplastic (melanoma)
0,228  0,007  Aromatase inhibitor
0,243  0,029  UGT2B15 substrate
0,276  0,065  Antineoplastic (glioma)
0,221  0,017  Farnesoid X receptor antagonist
0,212  0,013  Growth stimulant
0,301  0,106  CYP2C9 substrate
0,264  0,074  Chemoprotective
0,267  0,082  CYP2C19 substrate
0,186  0,003  RNA-directed RNA polymerase stimulant
0,187  0,008  SULT1E1 substrate
0,240  0,062  Psychostimulant
0,211  0,036  Toxic, respiratory center
0,204  0,030  Arachidonic acid antagonist
0,177  0,006  5-Alpha-reductase inhibitor
0,252  0,082  UGT1A9 substrate
0,175  0,005  Antiviral (RSV)
0,179  0,009  Estrogen agonist
0,177  0,008  Anabolic
0,170  0,005  Estrogen receptor beta agonist
0,193  0,030  DNA polymerase I inhibitor
0,204  0,045  Cholinergic
0,221  0,063  Carcinogenic
0,244  0,087  Antioxidant
0,174  0,017  Estrogen antagonist
0,197  0,042  NOS3 expression enhancer
0,195  0,041  UGT2B10 substrate
0,256  0,103  CYP2D6 substrate
0,157  0,005  Aldosterone antagonist
0,238  0,088  Interleukin agonist
0,175  0,027  Microtubule formation inhibitor
0,287  0,139  TNF expression inhibitor
0,239  0,097  Lipoprotein disorders treatment
0,163  0,024  UGT2B1 substrate
0,143  0,008  Cushing's syndrome treatment
0,152  0,032  Alcohol dehydrogenase substrate
0,148  0,028  Antineoplastic alkaloid
0,187  0,069  Antipruritic, non-allergic
0,170  0,052  Anesthetic
0,128  0,012  Na+ K+ transporting ATPase inhibitor
0,170  0,055  Lipid peroxidase inhibitor
0,128  0,014  Premenstrual syndrome treatment
0,117  0,007  Estrogen receptor alpha agonist
0,130  0,026  UGT2B11 substrate
0,129  0,024  Estrogen receptor beta antagonist
0,229  0,125  Antifungal
0,198  0,096  UGT1A6 substrate
0,129  0,027  Acetylcholine nicotinic antagonist
0,106  0,005  5-Alpha-reductase 2 inhibitor
0,135  0,036  Sulfotransferase substrate
0,209  0,110  DNA synthesis inhibitor
0,187  0,093  Antineoplastic (glioblastoma multiforme)
0,140  0,045  Menstruation disorders treatment
0,099  0,005  Lipocortins synthesis agonist
0,101  0,008  Mineralocorticoid receptor antagonist
0,177  0,084  Platelet adhesion inhibitor
0,144  0,053  Antihemorrhagic
0,231  0,141  Antileukemic
0,187  0,104  Hypolipemic
0,178  0,096  VEGF expression inhibitor
0,116  0,034  ABCA1 expression enhancer
0,093  0,013  SULT2A1 substrate
0,081  0,006  Glucocorticoid antagonist
0,078  0,005  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,135  0,062  Antihyperlipoproteinemic
0,075  0,004  Glucose-6-phosphate dehydrogenase inhibitor
0,210  0,141  Hypoxia-inducible factor 1 alpha inhibitor
0,188  0,119  Myocardial infarction treatment
0,109  0,042  Antineoplastic antibiotic
0,141  0,074  Skeletal muscle relaxant
0,181  0,116  NOS2 expression inhibitor
0,179  0,114  Antineoplastic (lymphoma)
0,066  0,007  Hypogonadism treatment
0,149  0,090  Interleukin 6 antagonist
0,086  0,030  Antitreponemal
0,143  0,089  UGT1A3 substrate
0,243  0,189  Analgesic
0,077  0,023  Andropause treatment
0,192  0,139  Cardioprotectant
0,154  0,101  Diabetic nephropathy treatment
0,145  0,094  Muscle relaxant
0,069  0,020  Acetylcholine M2 receptor agonist
0,163  0,115  Angiogenesis stimulant
0,051  0,005  Progesterone agonist
0,173  0,133  Cardiovascular analeptic
0,045  0,008  Estrone sulfatase inhibitor
0,053  0,017  Progesterone antagonist
0,092  0,057  Actinic keratosis treatment
0,084  0,051  T cell inhibitor
0,037  0,005  Hedgehog signaling activator
0,120  0,088  Antifungal enhancer
0,035  0,005  Corticosteroid-like
0,038  0,008  5-Alpha-reductase 1 inhibitor
0,053  0,023  Microtubule stabilization
0,161  0,132  Antineoplastic (cervical cancer)
0,100  0,071  Antiinfertility, female
0,146  0,117  LDLR expression enhancer
0,108  0,080  Autism spectrum disorders treatment
0,082  0,058  Acetylcholine M3 receptor agonist
0,077  0,053  Estrogen receptor alpha antagonist
0,075  0,051  Antibiotic
0,030  0,006  Glucocorticoid agonist
0,161  0,144  Antineoplastic (renal cancer)
0,073  0,056  SULT1A2 substrate
0,050  0,040  Protein 50S ribosomal subunit inhibitor
0,101  0,091  Acetylcholine antagonist
0,218  0,209  Antibacterial
0,102  0,093  Cholinergic antagonist
0,147  0,142  Neurotrophic factor enhancer
0,013  0,007  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,053  0,048  Postcoital contraceptive
0,114  0,109  Mutagenic
0,032  0,028  HMG CoA reductase inhibitor
0,006  0,004  Transcortin receptor antagonist
0,032  0,030  Tubulin agonist
0,020  0,020  Dopamine D1 agonist

